Concepedia
Statistics
Publications
16
Citations
1.6K
H-Index
13
Active since
2010
Affiliations
Rockefeller University(Current)
BioNTech (United States)
German Cancer Research Center
Heidelberg University
Boston University
Dewi Harjanto is an author at Rockefeller University specializing in life sciences, immunology, and cell biology.
Publications per year
2010–2024
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 743 citations · Full text
Medicine, Clinical Sciences, Oncology +17
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
Jennifer G. Abelin, Dewi Harjanto, Matthew Malloy et al. · Immunity · 2019 · 264 citations · Full text
Life Sciences, Immunology, Oncology +14
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
Asaf Poran, Dewi Harjanto, Matthew Malloy et al. · Genome Medicine · 2020 · 101 citations · Full text
Life Sciences, Bioinformatics, Immunology +17
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg et al. · Cell · 2023 · 89 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling
Dewi Harjanto, Joseph S. Maffei, Muhammad H. Zaman · PLoS ONE · 2011 · 61 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 16